Hostname: page-component-848d4c4894-m9kch Total loading time: 0 Render date: 2024-05-23T12:02:04.179Z Has data issue: false hasContentIssue false

MRI of Tibialis Anterior as “Surrogate Measure” in Myotonic Dystrophy Type 1

Published online by Cambridge University Press:  02 December 2014

Giovanni Meola*
Affiliation:
University of Milan, Milan, Italy
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Copyright
Copyright © Canadian Neurological Sciences Federation 2011

References

1 Machuca-Tzili, L, Brook, D, Hilton-Jones, D. Clinical and molecular aspects of the myotonic dystrophy: a review. Muscle Nerve. 2005;32:118.CrossRefGoogle ScholarPubMed
2 Turner, C, Hilton-Jones, D. The myotonic dystrophies: diagnosis and management. J Neurol Neurosurg Psychiatry. 2010;81:358–67.Google Scholar
3 Lee, JE, Cooper, TA. Pathogenic mechanisms of myotonic dystrophy. Biochem Soc Trans. 2009;37:12816.Google Scholar
4 Wiles, CM, Busse, ME, Sampson, CM, et al. Falls and stumbles in myotonic dystrophy. J Neurol Neurosurg Psychiatry. 2006;7: 3936.Google Scholar
5 Sackley, C, Disler, PB, Turner-Stokes, L, et al. Rehabilitation interventions for foot drop in neuromuscular disease. Cochrane Database Syst Rev. 2009;8:CD003908.Google Scholar
6 Coté, C, Hiba, B, Hebert, LJ, et al. MRI of tibialis anterior skeletal muscle in myotonic dystrophy type 1. Can J Neurol Sci. 2011; 38(1):112–18.Google Scholar
7 Heatwole, CR, Eiching, KJ, Friedman, DI et al. Open-label trial of recombinant human insulin-like growth factor 1/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1. Arch Neurol. 2010. Epub 2010 Sept 13.Google Scholar
8 Thornton, CA, Johnson, K, Moxley, RT. Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes. Ann Neurol. 1994;35:1047.Google Scholar